NEW
YORK, Feb. 21, 2025 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by
bluebird bio, Inc. (NASDAQ: BLUE) and its board of directors
concerning the proposed acquisition of the company by Carlyle
(NASDAQ: CG) and SK Capital Partners, LP. Stockholders will receive
$3.00 and a contingent value right of
$6.84 for each share of bluebird bio
stock that they hold. The transaction is expected to close in the
first half of 2025.
If you are a stockholder of bluebird bio, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/blue/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-bluebird-bio-inc-302382491.html
SOURCE Rowley Law PLLC
